RESULTS

Biological-chemical nanocomposites composed of titanium dioxide and DNA described by T. Rajh et al.
(in revision) can be introduced into mammalian HL60 cells in culture either alone or in combination with additional "free" oligonucleotides. Detection of these nanocomposites in cells was accomplished by detection of titanium using a hard X-ray fluorescence microprobe. We described some possible uses of the hard X-ray fluorescence microprobe for elemental mapping [1] ; here we specifically show detection of titanium that enables us to determine the cellular (and subcellular) localization of TiO 2 -DNA nanocomposites.
Grids with cells were mounted on standardized kinematic specimen holders and placed in the specimen chamber of the 2-ID-E X-ray fluorescence microprobe at the Advanced Photon Source at Argonne National Laboratory. The specimen chamber was filled with helium to optimize the detection of X-ray fluorescence of lighter elements, and to minimize the X-ray fluorescence background from argon gas in the air. A tunable, monochromatic X-ray beam from an undulator X-ray source was focused in a 0.5 µm x 0.3 µm spot using a Fresnel zone plate. Incident photon energy of 9.8 keV was chosen, which allows excitation of K α X-ray fluorescence in elements with atomic numbers Z between 15 (P) and 30 (Zn). An energy dispersive detector collected X-ray fluorescence radiation from the specimen; energy filtering of the measured spectra allowed identification of the elemental constituents in the illuminated specimen volume. To obtain a map of the elemental distribution in the cell, the specimen was scanned in x and y while recording the X-ray fluorescence spectra. We simultaneously mapped the fluorescent signatures of P, S, Cl, K, Ca, Ti, Mn, Fe, Cu, and Zn.
In Fig. 1 , X-ray fluorescence maps are shown of the elements P, S, Cl, K, Ca, Ti, Mn, Fe, Cu and Zn in an 82x82 µm area containing twenty-eight HL60 cells transfected with TiO 2 -DNA oligonucleotide nanocomposites. The map of the Ti distribution in this specimen shows that seven cells contain titanium as a consequence of transfection. Of these cells five had Ti signal peaks higher than 5 µg/cm 2 (blue color on this figure), and two lower. One such cell with a peak Ti signal higher than 5 µg/cm 2 is indicated by a pink arrow; it contains a total of 2.9x10 7 TiO 2 nanoparticles (each nanoparticle contains about 1400 Ti atoms). Fig. 2 shows a high resolution scan of a 12x12 µm 2 area of a single nucleus containing 3.6x10 6 nanoparticles. This nucleus was isolated from whole cells transfected with both TiO 2 -DNA nanocomposite, and a "free" DNA oligonucleotide. This scan demonstrates that the TiO 2 -DNA nanocomposites, once introduced into mammalian cells, reach the nucleus. A series of scans of the same type as above was obtained for 514 cells from 24 different samples of cells transfected with seven different Ti nanocomposites, either alone or in combination with "free" oligonucleotides. Table 1 presents the percentages of cells showing the presence of Ti signal. Chi square analysis (with 2 degrees of freedom) of the contingency table of these data showed, at a confidence level greater than 0.995, that there is an association of transfection success and addition of "free" oligonucleotides to transfection mixtures. Sequence of the "free" oligonucleotides, either identical to the sequence of the DNA attached to the nanocomposite or heterologus (different when compared to the sequence of oligonucleotide bound to Ti nanoparticle) did not affect this association. 
CONCLUSIONS
• Nanocomposites, a new tool for intracellular manipulations, can be engineered to provide biomolecules with novel functional properties (from the inorganic partner) and to provide inorganic molecules with unique specificity (from the bound DNA).
• Standard transfection methods can be employed to introduce TiO 2 -DNA nanocomposites into cells.
Once intracellular, these nanoparticles are able to translocate into the cell nucleus. • Addition of "free" oligonucleotides to cell transfection mixtures changes the numbers of transfected cells per total number of cells in the sample, and the peak Ti signal intensity in the transfected cells. • X-ray fluorescence excited in a hard X-ray microprobe can be used to quantify the success rate of transfection and reveal the intracellular distribution of the nanocomposites.
